Evidence map›Paper›PMID 41307832›Full record

SynthesisDrug safety2026

Systematic Review of Active Safety Surveillance of Vaccines and Medicines in Low- and Middle-Income Countries.

Andy Stergachis, Esperança Sevene, Mohammad Gazi Shah Alam, Rebecca E Chandler, Alexander Precioso, Samatha Mudigonda, Dale Nordenberg, Robert T Chen

Abstract readSystematic Review
In one paragraph

Synthesis in Drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andy StergachisUniversity of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA. stergach@uw.edu.ORCID http://orcid.org/0000-0003-0057-6627
Esperança SeveneSafety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.ORCID http://orcid.org/0000-0001-9025-4052
Mohammad Gazi Shah AlamUniversity of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0003-0551-9699
Rebecca E ChandlerCoalition for Epidemic Preparedness Innovation (CEPI), Oslo, Norway.ORCID http://orcid.org/0000-0002-9334-9046
Alexander PreciosoCoalition for Epidemic Preparedness Innovation (CEPI), Oslo, Norway.ORCID http://orcid.org/0000-0001-8657-9292
Samatha MudigondaSafety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.
Dale NordenbergSafety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.
Robert T ChenSafety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunctional active safety surveillance is essential for post-authorization assessment and life-cycle safety evidence generation of vaccines and medicines. Data collected through active surveillance methods are routinely used for post-approval surveillance of novel vaccines and medicines. Implementing these methods in low- and middle-income countries remains challenging.

objectiveThis systematic review identified and assessed existing active safety surveillance in low- and middle-income countries, including key features, strengths, and limitations.

methodsA search of EMBASE and PubMed Google Scholar databases was conducted. The protocol was registered with PROSPERO and adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Findings were synthesized narratively and categorized by surveillance systems characteristics.

resultsOf 13,027 records identified, 423 publications met inclusion criteria. Articles spanned 96 low- and middle-income countries, with India (96), China (57), Brazil (30), Iran (26), Ethiopia (21), Indonesia (20), Uganda (18), Kenya (17), and Ghana (16), most represented. The majority focused on vaccines (211). A total of 127 articles utilized mobile technologies for follow-up, online data collection, and/or adverse event reporting. Fifteen percent of vaccine surveillance systems described in articles demonstrated flexibility to incorporate new vaccines, 34% reported multi-sectoral collaborations, and 10% involved multiple countries. Gaps identified include small sample sizes, lack of sustainability, limited flexible surveillance, staffing challenges, and limited use of standard case definitions and digital technologies.

conclusionsActive safety surveillance in low- and middle-income countries has made progress but still faces challenges. The capture and management of safety data through harmonized digital tools that promote consistency in recording and reporting and cross-country collaborations are crucial in further strengthening active safety surveillance in low- and middle-income countries.

Indexed as

Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsProduct Surveillance, PostmarketingVaccinesDeveloping CountriesHumansVaccines

Identifiers

PMID41307832
PMCPMC13002750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.